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Dynamic tests of parathyroid hormone secretion using hemodi- The calcium-parathormone (PTH) curve described by
alysis and calcium infusion cannot be compared. Brown in 1983 demonstrated for the first time an inverse
Background. Extracellular Ca11 concentration [Ca11] and and sigmoidal relationship between calcium and PTH
parathormone (PTH) are related by a sigmoidal function. The
that could be represented by a mathematical model [1].set point of the control system is the [Ca11] that produces a
This investigator, studying parathyroid cells in vitro, usedhalf-maximal inhibition of PTH secretion. Whether or not this
set point is abnormal in patients with chronic renal failure a four-parameter formula [2] to construct this curve,
(CRF) and secondary hyperparathyroidism (SHP) is controver- which expresses the modulation of PTH secretion by the
sial. gland as a function of the variation in calcium concentra-
Methods. We investigated whether the way [Ca11] is varied
tion. In the same study, Brown demonstrated a right[hemodialysis (HD) or calcium gluconate/sodium citrate infu-
shift in the set point in patients with hyperparathyroidismsions (INF)] and the way the curve is constructed (four-parame-
compared with the controls, suggesting a lower sensitiv-ter model or adapted four-parameter, created by Felsenfeld)
could influence this set point. We performed dynamic tests of ity of parathyroid cells to calcium in these patients.
PTH secretion in 12 patients with CRF and SHP during either Later, Felsenfeld et al demonstrated that patients with
HD or INF. Both the four-parameter model or adapted four- chronic renal failure (CRF) and secondary hyperpara-parameter methods were used, creating four combinations: (a)
thyroidism (SHP) also presented a rightward shift of thehypocalcemia and hypercalcemia induced during HD, calcu-
set point compared with patients with low-turnover bonelated by Brown’s formula (HDB); (b) hypocalcemia and hyper-
calcemia induced during HD, calculated by Felsenfeld’s for- disease [3]. By inducing hypercalcemia and hypocal-
mula (HDF); (c) hypocalcemia and hypercalcemia induced cemia by varying the calcium concentration in the dialysis
during infusion, calculated by Brown’s formula (INFB); and solution, these authors calculated the set point using an
(d) hypocalcemia and hypercalcemia induced during infusion, adaptation of the formula originally used by Brown [1].calculated by Felsenfeld’s formula (INFF).
Several authors have used the calcium-PTH curve in theResults. The set points obtained with HDB correlated per-
original [4] or adapted [5] form as a method for evalua-fectly with those obtained with HDF (R2 5 0.999). A similar
relationship was found between INFB and INFF (R2 5 0.9997). tion and therapeutic follow-up of patients with renal
In contrast, there was no correlation between either HDB and osteodystrophy. In 1993, Ramirez et al conducted a com-
INFB (R2 5 0.0157) or HDF and INFF (R2 5 0.0204). parative study on normal individuals and CRF patients
Conclusions. These findings indicate that the calculated
with hyperparathyroidism [6]. Different from the other[Ca11] set point in patients with CRF and SHP is determined
studies, these patients were younger (mean age of 15 6by the way [Ca11] is varied, rather than by the mathematical
3 years) and were on chronic ambulatory peritoneal dial-model used to generate the curves. Further studies are needed
to determine the differing physiological mechanisms triggered ysis (CAPD). Hypocalcemia and hypercalcemia were
by HD and INF and the way they influence [Ca11] homeostasis induced outside of the dialysis process by intravenous
in this setting. infusion of hypocalcemic and hypercalcemic substances.
The set point was calculated by the method of Brown,
and no differences were found between groups, sug-
Key words: chronic renal failure, secondary hyperparathyroidism,
gesting that no changes in set point values occurred inFelsenfeld’s formula, Brown’s formula, math model, calcium homeo-
stasis. uremic patients with SHP compared with normal individ-
uals [1].Received for publication June 18, 1998
Thus, a debate arose about the set point values in SHPand in revised form February 16, 1999
Accepted for publication February 21, 1999 [7–9]. In a recent study, Dru¨eke pointed out the need
to clarify this doubt [10] because it is not possible to 1999 by the International Society of Nephrology
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Table 1. General characteristics and basal biochemical parameters or if calcium levels reached 0.9 and 1.4 mmol/liter during
of the patients
the induction of hypocalcemia and hypercalcemia, re-
Mean sd spectively. The test was interrupted after two hours, even
Age years 31.17 8.94 if these values were not reached. Calcium levels were
Sex ratio men/women 5/7 then monitored at 20 minute intervals until they returned
HD time years 8.17 3.56
to basal values. The samples for the measurement ofBasal PTHi 912.0 347.0
Total calcium mg/dl 8.98 0.66 ionized calcium were processed immediately with a Ciba
Phosphorus mg/dl 5.43 1.16 Corning autoanalyzer, and the samples for PTH mea-
Albumin g/liter 4.38 0.51
surement were stored on ice and centrifuged for laterAlkaline phosphatase IU/liter 1094.25 879.13
measurement by radioimmunoassay with a CIS kit (nor-N 5 12. Normal values are: PTHi, 7–76 pg/ml; calcium, 8.5–10.5 mg/dl; phos-
phorus, 2.3–4.6 mg/dl; albumin, 3.5–5.0 mg/dl; alkaline phosphatase, 60–170 IU/ mal range, 8 to 76 pg/ml; CIS Bio International, ORIS
liter. Group, Gif-Sur-Yvette, France).
The variation in calcium during HD was produced as
described by Felsenfeld et al [3]; that is, low-calcium HD
(0 mmol/liter) was performed to induce hypocalcemia,compare data obtained by Felsenfeld et al and Ramirez
and high-calcium HD (2 mmol/liter) was performed toet al in view of the different methods of calcium variation
induce hypercalcemia. The membrane used was cupro-and the construction of the calcium-PTH curve used by
phane. The dialysate buffer was bicarbonate, and thethese authors [3, 6].
dialysis was performed without ultrafiltration.Our study’s purpose was to evaluate the parathyroid
The induction of hypocalcemia and hypercalcemia byfunction of individuals with CRF and SHP by con-
infusion was performed according to the protocol pro-structing their calcium-PTH curve with the induction
posed by Ramirez et al [6]. In brief, the serum-ionizedof hypocalcemia and hypercalcemia using two different
calcium levels were lowered by an intravenous infusionmethods, that is, hemodialysis (HD) with different con-
of sodium citrate (USP formula A). The initial dose
centrations in calcium dialysate and hypocalcemic and
of citrate was 28 mg/kg/hr, and the infusion rate was
hypercalcemic substances’ infusion. The data obtained
increased by 5 mg/kg/hr every 10 minutes during the first
were analyzed in two ways: according to the original
hour and by 10 mg/kg/hr during the second hour to obtain
proposal of Brown and according to the proposal of the decline in serum calcium. Hypercalcemia was ob-
Felsenfeld et al [1, 3]. tained by an intravenous infusion of 10% calcium gluco-
nate (9.3 mg/ml calcium). The initial dose of calcium
gluconate was 2 mg/kg/hr and was increased by 1 mg/METHODS
kg/hr every 20 minutes.Patients
Patients underwent the four tests on different days,
We studied 12 patients with CRF aged 15 to 50 years with an interval of at least 24 hours between each test
who had been on HD for at least two years. All presented (mean interval of 2 days). One half of the patients under-
evidence of SHP as documented by radiological signs went their infusion test first, and the others started the
and by an intact PTH value of at least six times higher study with the dialysis test.
than normal (Table 1). Aluminum intoxication was ruled After the infusion and dialysis tests, we constructed
out in nine patients by bone biopsy. The extent of stain- the curves for each patient according to the calculations
able aluminum was 0% in seven patients and less than elaborated by Brown and Felsenfeld et al [1, 3]. We
15% in two patients. After admission to the study, the observed the phenomenon of gland exhaustion (in the
patients were instructed to discontinue the use of hypocalcemia part of the curve, after PTH had plateaued
calcitriol, and to control their plasma phosphorus levels at maximal levels, further decreases in serum calcium
through the diet and the use of calcium-chelating agents. led to decreases in PTH levels) in eight patients during
Parathyroid function was studied at least three weeks infusion and in seven patients in HD. These points were
after the discontinuation of calcitriol and the stabiliza- excluded from the curve because it was a separate pro-
tion of calcium and phosphorus levels. cess from those involved in generating the sigmoidal
relationship between calcium and PTH. Brown’s slope
Analysis of parathyroid function and set point were generated by using a standard nonlin-
The test was done after an eight-hour fast, with the ear least-squares algorithm (Graph Pad Prism). Felsen-
patient at rest. Before each study, vital signs were ob- feld’s set point was calculated according his definition
tained and were monitored during the test. Blood sam- [3], and the slope was calculated using the maximal 25%
ples were collected at 10 minute intervals for the mea- and the minimal 15%.
surement of intact PTH and ionized calcium. The test Thus, we analyzed four curves for each patient: (a)
hypocalcemia and hypercalcemia induced during HD,was interrupted if the patient presented any symptoms
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Table 2. Set point and slope values
Set point Slope
Patient HDB HDF INFB INFF HDB HDF INFB INFF
1 1.108 1.109 1.035 1.036 26.10 24386 212.36 23632
2 1.143 1.143 1.068 1.069 26.83 22648 210.58 23513
3 1.128 1.128 1.052 1.053 211.86 210237 25.79 25013
4 1.081 1.081 1.066 1.066 29.99 26284 227.87 24242
5 1.010 1.010 0.998 0.998 225.87 21806 29.55 22560
6 1.080 1.081 1.065 1.065 27.67 24576 210.55 24341
7 1.136 1.136 1.146 1.147 26.76 26296 26.17 24789
8 1.035 1.036 1.062 1.063 28.20 21342 28.94 21967
9 1.009 1.009 1.125 1.126 221.62 213509 28.69 24263
10 1.117 1.118 1.181 1.186 273.06 214499 222.78 212251
11 1.018 1.018 1.043 1.043 27.16 2986 26.94 21239
12 1.089 1.090 1.189 1.190 24.79 22738 26.29 23987
Mean 1.080 1.079 1.085 1.086 215.83 25776 211.30 24316
sd 0.050 0.050 0.060 0.061 19.16 4624 6.94 2746
N 5 12. Abbreviations are: HDB, hemodialysis, Brown’s formula; HDF, hemodialysis, Felsenfeld’s formula; IFB, infusion, Brown’s formula; IFF, infusion
Felsenfeld’s formula. Set point values are expressed as mmol /liter.
calculated by Brown’s formula (HDB) [1]; (b) hypocal-
cemia and hypercalcemia induced during HD, calculated
by Felsenfeld’s formula (HDF) [3]; (c) hypocalcemia and
hypercalcemia induced during infusion, calculated by
Brown’s formula (INFB) [1]; (d) hypocalcemia and hy-
percalcemia induced during infusion, calculated by
Felsenfeld’s formula (INFF) [3].
Statistical analysis
The results are given as mean 6 sd. A P value , 0.05
was considered significant. Simple linear regression was
used to compare the four curves concerning set point
values. We also used simple linear regression to compare Fig. 1. Individual set point values. Numbers 1 through 12 show the
individual identification of each patient. Abbreviations are: HDB, he-HD and infusion regarding slope values. We compared
modialysis, as calculated by Brown’s formula; HDF, hemodialysis, asthe basal serum calcium for each patient using one-way calculated by Felsenfeld et al’s formula; INFB, infusion, as calculated
analysis of variance. The same was done for basal PTH. by Brown’s formula; INFF, infusion, as calculated by Felsenfeld et al’s
formula.A profile analysis was used to compare HD and infu-
sion concerning maximum PTH, minimum PTH, basal
PTH, time to obtain maximum calcium, time to obtain
minimum calcium, basal/maximum PTH, minimum/basal ever, when infusion was used instead of HD, 33.33% of
PTH, and minimum/maximum PTH. The mean data for the patients did not show a change in set point, 41.7%
our population and the values of its calcium-PTH curve presented an increase and 25% a decrease. Figure 2
were compared with those of Felsenfeld et al and Rami- illustrates the relationship between the set point values
rez et al by the unpaired Student’s t-test [3, 6]. obtained in the four curves studied for each patient.
When we compared the set points obtained during dial-
ysis, we confirmed an excellent adjustment (R2 5 0.9999;
RESULTS Fig. 2A), and the same occurred when we compared the
Table 2 shows the set point and slope values obtained values obtained during infusion (R2 5 0.9997; Fig. 2B).
in the four analyses, that is, HDB, HDF, INFB, and However, the set point values obtained during dialysis
INFF. While it could be seen that the mean set point and infusion are not comparable. In Figure 2C, we com-
values were similar, analysis of individual data for each pared HDB and INFB and proved that the set point
patient did not confirm this initial impression. Figure 1 values were different for the same patient (R2 5 0.0157).
illustrates the behavior of the set point in the four situa- Figure 2D compares HDF and INFF (R2 5 0.0204), con-
tions studied. The set point values were similar regardless firming the difference detected in Figure 2C. Thus, the
of whether the curve was constructed by the method of way the curve was constructed (either the classic four-
parameter formula or its modification) did not changeBrown or by the method of Felsenfeld et al [1, 3]. How-
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Fig. 2. Analysis of set point values: Linear regression from the four values obtained for each patient. (A) Hemodialysis set point value according
to Brown (x axis) and Felsenfeld (y axis) (R2 5 0.9999). (B) Infusion set point values according to Brown (x axis) and Felsenfeld (y axis) (R2 5
0.9997). (C) Brown’s set point hemodialysis (x axis) and infusion (y axis) values (R2 5 0.9157). (D) Felsenfeld’s set point values for hemodialysis
(x) and infusion (y) (R2 5 0.0204).
Table 3. Basal PTH and ionized calcium values for the four tests Table 2 shows that there were no differences in the
slope values obtained by HD and infusion either byINFhypo INFhyper HDhypo HDhyper
Brown’s formula (R2 5 0.1636) or by Felsenfeld et al’sCalcium 1.09760.083 1.08460.079 1.09160.080 1.09560.089
PTH 908.36354.9 978.56408.8 794.56260.1 839.36301.6 adaptation (R2 5 0.2198) [1, 3]. Testing the hypothesis
Abbreviations are: INFhypo, hypocalcemia induced by sodium citrate infu- that the regression equation is equal to the bisectrix, we
sion; INFhyper, hypercalcemia induced by calcium gluconate infusion; HDhypo, obtained no significant results (P 5 0.6170 for Brown’shypocalcemia induced by hemodialysis; HDhyper, hypocalcemia induced by he-
modialysis. Data are N 5 12; mean 6 sd. Normal values are: ionized calcium, curve and P 5 0.2198 for Felsenfeld et al’s adaptation),
1.12–1.25 mmol/liter; PTH, 7–76 pg/ml. confirming that the slope values were similar for HD
and infusion.
Table 4 presents basal PTH values (PTHbas), maximum
PTH (PTHmax), minimum PTH (PTHmin), basal calciumthe set point values, but the method used to induce
(Cabas), maximum calcium (Camax), minimum calciumcalcium variation (dialysis or infusions) produced sig-
(Camin), and time to obtain Camax and Camin for both HDnificant differences in this parameter. The analysis of
and INF. There were no differences in PTHbas, Cabas,basal calcium and PTH values from each patient confirms
PTHmax, Camax, Camin, or the time to obtain Camax in boththat they were in the same basal status in the beginning
situations. However, there was a significant differenceof the different tests (Table 3).
(P , 0.05) in PTHmin values obtained by HD (207.70 6We found a positive correlation between basal calcium
104.33 pg/ml) and by INF (162.9 6 73.28 pg/ml), and thevalues and set point both with HDF (r 5 0.76, P , 0.01)
time to obtain Camin was shorter by HD than by INFand INFB (r 5 0.64, P , 0.05), but we did not find any
correlation between basal PTH values and set point. (104.17 6 21.93 vs. 81.67 6 26.22, P , 0.005).
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Table 4. PTH and ionized calcium values and by Ramirez et al (1.22 mmol/liter, P , 0.0005) [3,
6]. Furthermore, our set point values obtained with HDHD INF P
(1.079 mmol/liter) and with infusion (1.085 mmol/liter)PTHbas pg/ml 912.0 (347.0) 835.0 (274.0) 0.23
PTHmax pg/ml 2301.0 (1423.0) 1748.0 (610.0) 0.11 were lower than those obtained by the previously men-
PTHmin pg/ml 208.0 (104.0) 163.0 (73.0) ,0.05 tioned authors (1.18 mmol/liter [3] and 1.24 mmol/liter
Cabas mmol /liter 1.08 (0.08) 1.09 (0.07) 0.58 [6], with P , 0.0001 in both cases). These biochemicalCamax mmol /liter 0.93 (0.10) 0.96 (0.07) 0.49
Camin mmol /liter 1.35 (0.07) 1.36 (0.05) 0.56 findings may reflect possible differences between our
Time Camax min 15.83 (7.92) 19.17 0.22 population and others previously studied, perhaps be-
Time Camin min 81.67 (26.22) 104.17 (21.93) ,0.005 cause of the associated malnutrition that is frequently
Data are: mean 6 sd; N 5 12; paired data. observed in our patients [11], which most likely contrib-
utes to a higher PTH secretion.
In any case, these characteristics did not change our
findings, as our objective was to compare the data ob-DISCUSSION
tained for the same patient, and therefore, the important
A variety of techniques have been employed to study point was that the patients should be in similar basal
the regulation of PTH release in hyperparathyroidism condition in all tests. This similarity was proved by the
in vivo and in vitro, and conflicting results have been results of basal PTH and ionized calcium, which did not
obtained with both approaches. differ significantly in any of the situations studied.
The original study by Brown was carried out in vitro The correlation between basal calcium and set point
using parathyroid cells [1], and the study by Felsenfeld values, also observed in a recent study by Borrego et
et al was carried out in vivo, with some adaptations that al [12], confirms the influence of basal calcium on the
cannot be ignored [3]. First, hypocalcemia and hypercal- calcium-PTH curve. The current study showed that a
cemia were induced during HD. The patients underwent sustained change in serum calcium may lead to a propor-
dialysis with different calcium concentrations: elevated tional adaptation of the set point, but the analysis of the
calcium for the induction of hypercalcemia and low cal- influence of acute changes of basal calcium over set point
cium for hypocalcemia, with a consequent simplification was not performed. Our study was done in a short time
of the construction of the calcium-PTH curve. A second period and without variations of basal calcium during
aspect to be considered is how Felsenfeld et al defined the four tests (Table 3). Therefore, the differences among
the set point and the slope of the curve [3]. These authors set point values were not due to differences in basal
defined the set point as PTHmax/2, whereas Brown consid- calcium values.
ered the set point as the calcium value obtained in the We demonstrated changes in individual set point by
middle of the curve [1], that is, (PTHmax 1 PTHmin)/2. In simply modifying the form of induction of hypocalcemia
the original study, Brown determined the slope value by and hypercalcemia. When analyzing the individual be-
a complex four parameter mathematical formula where havior of the set point of each patient, we noted no
Y 5 {(A 2 D)/[1 1 (X/C)B]} 1 (D)2 [1]. On other hand, variation when the calculation was performed by the
Felsenfeld et al obtained this value by using the formula four parameter formula or by its adaptation. These find-
of [3]: slope 5 (PTHmax 2 PTHmin)/(Camax 2 Camin), where ings agree with those reported by Felsenfeld and Rodri-
Camax was the calcium value at which PTHmax was ob- guez [8]. These authors found a 0.97 correlation between
tained and Camin the value of PTHmin. the set point values calculated in two different manners.
The propose of our study was to compare the two However, we have also seen variations in set point when
forms of hypocalcemia and hypercalcemia induction, and the latter is calculated during HD or INF, with no pattern
to analyze the formulas used for the construction of the in this variation. Some patients presented a higher set
calcium-PTH curve applying all of these tests to the same point in HD than in INF, whereas the opposite occurred
patient. in others.
Our first interesting finding concerns the characteris- Thus, the same patient may present different set point
tics of the population studied. Some of our patients pre- values, depending on the type of induction of hypocal-
sented severe hyperparathyroidism with serious symp- cemia and hypercalcemia. This is probably related to
toms, evident clinical impairment, and high PTH values changes in pH [13], osmolarity [14], glucose [14], phos-
that were similar to those in Felsenfeld et al’s study [3] phorus [15], and other variations that occur during HD
and approximately double that reported by Ramirez et and that may interfere with PTH secretion.
al [6]. However, these findings were not accompanied Another relevant result was the confirmation that the
by high calcium or phosphorus values, as is frequently rate of ionized calcium variation can also affect the
reported in the literature. The mean basal ionized cal- rhythm of PTH secretion. There were no differences
cium value (1.09 mmol/liter) was lower than the values between HD and INF in terms of maximum calcium,
maximum PTH, or time needed to obtain maximum cal-reported by Felsenfeld et al (1.14 mmol/liter, P , 0.05)
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cium. Minimum calcium levels were similar in HD and mia. All of these differences in the form of calcium varia-
tion generated different set point findings, therefore pre-in infusion, but the time needed to obtain them was
longer in the infusion than in HD. In agreement with venting any comparison between studies, as demon-
strated in our investigation.this result, minimum PTH values were lower in the infu-
sion than in HD, that is, the time needed to obtain them Thus, any study aiming at the identification of differ-
ences in set point should be conducted using the samewas shorter in HD than in INF, leading to different
minimum PTH values. This finding is one more confir- form of induction, the same rate of calcium variation,
and on patients of similar basal situations. Only by obey-mation that the rate at which the extracellular calcium
concentration changes is what modulates the parathyroid ing these criteria will the set point values have the neces-
sary reliability to permit the determination of the dy-cell secretory response, although there is some contro-
versy regarding this point. In 1991, Brown demonstrated namic parathyroid behavior in SHP.
that there is a rate-dependent control of PTH during
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